Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 16,490 | 17,006 | 13,494 | 37,227 | 9,251 |
| Operating Income | -16,490 | -17,006 | -13,494 | -37,227 | -9,251 |
| Other Income | 367 | 464 | 325 | 384 | 392 |
| Pre-tax Income | -16,123 | -16,542 | -13,169 | -36,843 | -8,859 |
| Net Income Continuous | -16,123 | -16,542 | -13,169 | -36,843 | -8,859 |
| Net Income | $-16,123 | $-16,542 | $-13,169 | $-36,843 | $-8,859 |
| EPS Basic Total Ops | 26.34 | -0.97 | -9.21 | -24.29 | -7.94 |
| EPS Basic Continuous Ops | 23.25 | -0.93 | -7.37 | -22.44 | -5.81 |
| EPS Diluted Total Ops | 26.34 | -0.97 | -9.21 | -24.29 | -7.94 |
| EPS Diluted Continuous Ops | 23.25 | -0.93 | -7.37 | -22.44 | -5.81 |
| EBITDA(a) | $-15,971 | $-16,490 | $-12,980 | $-36,723 | $-8,742 |